Skip to content
RDL Network logo
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: Efficacy, safety, and clinical benefit assessment — Eleni Efstathiou (2005) | RDL Network